Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenoma × Mesalamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms, Hereditary Nonpolyposis 2 Colorectal Neoplasms 2 Recurrence 1 Neoplasms 1 Colonic Neoplasms 1 Adenoma 1

Interventions

defactinib 1 Sunitinib 1 Mesalamine 1 Mass Screening 1 Folic Acid 1 Colonoscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01894685 2015-12-08

Mesalazine Effects in Sporadic Colorectal Adenoma Patients

UMC Utrecht

Phase 2 Completed

Adenoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡